10-Q: Gold Flora Corporation Reports First Quarter 2024 Results, Revenue Jumps 105%

Gold Flora Corporation's first quarter 2024 results show a significant revenue increase of 105% compared to the same period last year, driven by both wholesale and retail growth.

Summary

• Gold Flora Corporation reported a net loss of $13.7 million for the quarter ended March 31, 2024, compared to a net loss of $9.3 million for the same period in 2023.
• The company's revenue increased by 105% to $32.2 million in Q1 2024, up from $15.7 million in Q1 2023.
• Wholesale revenue increased by 70.1% to $5.2 million, while retail revenue increased by 114.1% to $26.9 million.
• The company's gross profit was $10.0 million, with an adjusted gross profit of $17.4 million.
• Operating expenses totaled $19.0 million, an increase from $8.9 million in the prior year.
• The company's cash and cash equivalents decreased to $14.2 million from $22.5 million at the end of 2023.
• The company is working to remediate a material weakness in internal controls over financial reporting.

Sentiment

Score: 5

Explanation: The document presents mixed signals. While there is strong revenue growth and strategic initiatives, the significant net loss, cash burn, and material weakness in internal controls temper the positive aspects. The need for additional capital also adds uncertainty.

Positives

• The company experienced a significant increase in revenue, driven by both wholesale and retail segments.
• The launch of the Gramlin product brand is expected to appeal to high-volume consumers.
• The company has successfully streamlined and integrated legacy operations, reducing costs.
• The company is expanding its cultivation capacity, which is expected to increase flower production.
• The company has centralized its manufacturing operations, improving efficiency.
• The company has strategically increased the number of third-party dispensary accounts buying from Stately Distribution.
• The company has expanded its retail footprint, enhancing its market position for Gold Flora owned branded products.

Negatives

• The company reported a net loss of $13.7 million for the quarter.
• Operating expenses increased significantly to $19.0 million.
• Cash and cash equivalents decreased to $14.2 million.
• The company has identified a material weakness in its internal control over financial reporting.
• The company is subject to the limitations of Internal Revenue Code (IRC) Section 280E, which limits deductible expenses.

Risks

• The company's operations are subject to the Controlled Substances Act of the United States of America, which considers cannabis an illegal activity.
• The company has sustained annual losses since inception and may require additional capital in the future.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company is subject to a variety of local and state regulations, and failure to comply could result in fines or restrictions.
• The company is involved in litigation with Shelf Life Inc.
• The company is in negotiations to extend the maturity dates of promissory notes with Skyfall Partners, LLC and BlackStar Capital Partners, LLC.
• The company is subject to potential regulatory fines, penalties, or restrictions in the future.

Future Outlook

The company plans to continue to be one of the leading cannabis companies in California, focusing on profitable organic and strategic opportunities with a focus on sustainable cash flow. The company anticipates opening a 17th dispensary in Costa Mesa in the second half of 2024 and plans to raise additional financing if needed to help fund operations.

Management Comments

• The company has diligently and successfully accomplished targeted measures to streamline and integrate legacy operations into our vertically-integrated platform.
• The availability of owned down-stream retail outlets has been instrumental in developing and launching new owned brands such as Gramlin.
• We continue to increase our cultivation capacity at the DHS Campus and San Jose campus.
• We have centralized our manufacturing at the DHS Campus and approximately 200 SKUs move through the operation on a monthly basis.
• We have strategically increased the number of third party dispensary accounts buying from Stately Distribution contributing to better overall product management and successful brand launches.

Industry Context

The company's performance reflects the ongoing growth and consolidation within the California cannabis market. The focus on vertical integration and brand development aligns with industry trends aimed at improving profitability and market share. The company's expansion of cultivation and manufacturing capacity is a strategic move to control its supply chain and reduce reliance on third-party vendors.

Comparison to Industry Standards

• Compared to other vertically integrated cannabis companies in California, Gold Flora's revenue growth of 105% is significant, indicating strong market traction.
• Companies like Curaleaf and Trulieve, which operate in multiple states, have reported similar strategies of vertical integration to improve margins, but Gold Flora is focused on the California market.
• The company's adjusted gross profit margin of 54.1% is competitive with other established cannabis operators, but the net loss indicates that the company is still in a growth phase.
• The company's focus on brand development with the launch of Gramlin is similar to strategies employed by other cannabis companies to differentiate themselves in a competitive market.
• The company's expansion of cultivation capacity is in line with the industry trend of increasing production to meet growing demand.

Legal Proceedings

• The company is currently in active litigation with Shelf Life Inc.
• Certain dissenting TPCO shareholders have asserted that the fair value of their TPCO Shares was higher than the trading price of June 14, 2023 and should have been determined to be at least US$0.9847 per TPCO Share. However, the ultimate amount required to be paid by Gold Flora is subject to determination by the Supreme Court of British Columbia.

Related Party Transactions

• The company has various related party transactions, including facility rent, construction of facilities, shared services, and interest expenses with entities co-owned or managed by shareholders, directors, and officers.
• The company has promissory notes with Skyfall Partners, LLC and BlackStar Capital Partners, LLC, entities majority owned by a shareholder of the company.

Stakeholder Impact

• Shareholders are impacted by the net loss and the need for additional capital.
• Employees are impacted by the company's restructuring activities and cost-cutting measures.
• Customers are impacted by the launch of new products and the expansion of retail locations.
• Suppliers are impacted by the company's efforts to optimize its supply chain.
• Creditors are impacted by the company's debt obligations and the potential need for additional financing.

Next Steps

• The company plans to continue to work to fully remediate the material weakness in internal control over financial reporting.
• The company plans to continue to evaluate additional opportunities for cost reductions and business optimizations to reduce cash use.
• The company plans to accelerate profitable market share growth and improve gross margin profile.
• The company plans to work toward generating sustained free cash flow over the longer term.
• The company plans to open a 17th dispensary in Costa Mesa in the second half of 2024.
• The company plans to raise additional capital as needed.

Key Dates

Keywords

cannabis, cultivation, manufacturing, distribution, retail, wholesale, California, financial results, revenue, net loss, EBITDA, adjusted EBITDA, internal controls, material weakness, Gramlin, vertical integration